Efficacy of tonsillectomy in a family with a PFAPA-like phenotype by Alpigiani MG, Haupt M, Calcagno A, Gattorno M, Ceccherini I, Tambroni B

Connect to this object online.

Abatacept for severe anti-TNF-alfa refractory JIA-associated uveitis: one year follow-up by Traverso CE, Papadia M, Bagnis A, Callegari S, Salvati P, Alpigiani MG, Lorini R

Connect to this object online.

Use of bone marrow cells (BMCS) added to Platelet-Rich Plasma (PRP) for treatment of bone degenerative processes in JIA patients: a case report by Michelis MB, Lorini R, Tripodi G, Callegari S, Muraca M, Salvati P, Alpigiani MG, Boero S

Connect to this object online.

Thalidomide: efficacy and side effects in juvenile idiopathic arthritis (JIA) by Alpigiani MG, Lamba L Doria, Haupt M, Calcagno A, Poggi E, Salvati P, Lorini R

Connect to this object online.

Adalimumab and severe uveitis in juvenile idiopathic arthritis (JIA) therapy by Alpigiani MG, Calcagno A, De Marco R, Haupt M, Salvati P, Poggi E, Lorini R

Connect to this object online.

JIA affected sibling pairs present high correlation for ANA and ILAR category by Alessio M, Lepore L, Calcagno G, Trauzeddel R, Falcini F, Cortis E, Alpigiani MG, Rumba I, Dressler F, Balogh Z, Zulian F, Pruunsild C, Herlin T, Nielsen S, Stanevicha V, Foeldvari I, Malattia C, Filocamo G, Glass DN, Thompson SD, Martini A, Ruperto N

Connect to this object online.

8.5 Predictors of long-term outcome of Juvenile Dermatomyositis (JDM): a Multicenter, Multinational Study of 490 patients by Ferrari C, Trail L, Pilkington C, Maillard S, Cuttica R, Katsicas MM, Russo R, Bandeira M, Ferriani V, Oliveira S, Saad-Magalhaes C, Silva CA, Baca V, Burgos-Vargas R, Solis-Vallejo E, Alessio M, Alpigiani MG, Corona F, Falcini F, Gerloni V, Lepore L, Magni-Manzoni S, Zulian F, Ruperto N, Pistorio A, Felici E, Rossi F, Sala E, Martini A, Ravelli A

Connect to this object online.